Status:
RECRUITING
A Prospective Cohort Study of IRPF in China
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Idiopathic Retroperitoneal Fibrosis
Eligibility:
All Genders
18-75 years
Brief Summary
This is a cohort study to investigate the disease course and treatment response of patients with idiopathic retroperitoneal fibrosis（IRPF）. Methods: All the patients fulfilling diagnostic criteria of...
Detailed Description
Idiopathic retroperitoneal fibrosis（IRPF） is a rare fibro-inflammatory disease that develops around the abdominal aorta and the iliac arteries, and spreads into the adjacent retroperitoneum, where it ...
Eligibility Criteria
Inclusion
- Males and females; 18-75 years old with informed consent; Patients diagnosed with definite or possible IRPF.
Exclusion
- Secondary forms of IRPF; Pregnant or Females planning to bear a child recently ; Concurrent severe and/or uncontrolled and/or unstable diseases; Patients with malignancy.
Key Trial Info
Start Date :
January 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04312854
Start Date
January 17 2020
End Date
January 1 2030
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100032